Emil Kuriakose - Jan 23, 2023 Form 4 Insider Report for Calithera Biosciences, Inc. (CALA)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Emil Kuriakose
Stock symbol
CALA
Transactions as of
Jan 23, 2023
Transactions value $
-$35
Form type
4
Date filed
1/25/2023, 03:00 PM
Previous filing
Jan 27, 2022
Next filing
Mar 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CALA Common Stock Tax liability -$35 -79 -2.18% $0.45 3.54K Jan 23, 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on January 23, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
F3 Includes 125 shares acquired on each of June 10, 2022 and December 9, 2022, under the Company's 2014 Employee Stock Purchase Plan.